 |
10.9.2012 Xcellerex Founder, Chief Technology Officer Parrish Galliher Named as a "Thought Leader of the Decade" in 2012 BioProcess International Awards more 6.15.2012 Xcellerex Introduces XDR-10 Single-Use Bioreactor for Benchtop Use more 5.10.2012 GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc. more 5.2.2012 Xcellerex Launches Intelligent Single-Use Mixing Systems for Single-Use Biomanufacturing more 3.12.2012 New White Paper: How a Flexible Bioprocessing Platform Meets the Changing Needs of Biomanufacturing more 3.7.2012 GE Healthcare to acquire Xcellerex Inc., broadening capabilities in growing biopharmaceutical manufacture segment. more Xcellerex named to Inc. Magazine's list of fastest growing companies. more Xcellerex introduces 10 Liter XDR-10 Single-Use Bioreactor more Xcellerex Announces Sale of FlexFactory Bioproduction Line to R-Pharm for New Manufacturing Facility in Russia more Xcellerex® and Gallus BioPharmaceuticals Announce Biomanufacturing Collaboration. more First clinical trial results of Xcellerex inactivated vaccine against yellow fever published in New England Journal of Medicine. more Xcellerex Welcomes ISPE Japan Dignitaries for Tour of New FlexFactory® Biomanufacturing Facility. more Xcellerex recognized by Invensys with 2010 Productivity Excellence Award. more GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program. more Xcellerex Signs Memorandum of Understanding with SK Chemicals to Commercialize SK-Developed Vaccines with FlexFactory® Platform. more Xcellerex announces groundbreaking for new FlexFactory facility. more Xcellerex and partners announce completion of successful test of Rapid Production of Swine Flu H1 Hemagglutinin. more 
|
 |
